Next-Gen GLP-1 Agonists: Retatrutide, Orforglipron, CagriSema & Beyond

General · 5 · April 23, 2026

Triple agonists, oral pills, amylin combos — the next wave of GLP-1 drugs promises 25%+ weight loss and better diabetes control. Here's every major candidate in 2026.